Dynavax Technologies 8-K Filing: Key Insights from February 2025 Report
From the provided section of the financial report, here are the key pieces of information extracted:
- Company Information:
- Name: Dynavax Technologies Corporation
- CIK: 0001029142
- Address: 2100 Powell Street, Suite 720, Emeryville, CA 94608
- Phone Number: 510-848-5100
- Filing Information:
- Filing Type: 8-K
- Filing Date: February 10, 2025
- SEC File Number: 001-34207
- IRS Number: 33-0728374
- Stock Information:
- Common Stock Par Value: $0.001
- Stock Symbol: DVAX
- Exchange: NASDAQ
- Reporting Period:
- Start Date: February 3, 2025
- End Date: February 3, 2025
- XML and XBRL Information:
- The report is in XBRL format, indicating it is structured for digital reporting and analysis.
- It includes schema reference for further data interpretation.
Insights:
- The filing is classified as an 8-K, which typically reports unscheduled material events or corporate changes. The specific nature of the events reported in this filing would need to be reviewed in the full document.
- The reporting period is quite short, indicating this might pertain to a specific event or transaction that occurred on that single day (February 3, 2025).
- The listing on NASDAQ under the ticker DVAX indicates the company is publicly traded, which may provide additional insights into its financial health and market performance.
For a deeper analysis, it would be necessary to review the complete 8-K filing to understand the specific events or material information disclosed.